Glioblastoma E Book

Clinically focused and designed to provide a to-the-point overview, Glioblastoma , by Drs. Steven Brem and Kalil G. Abdullah, brings you up to date with increased understanding, new treatment protocols, and recent advances in the field. Written by contributing specialists who are global experts in their respective areas, this one-stop reference provides neurosurgeons, medical-and-radiation oncologists, neuro-oncologists, neuropathologists, internal medicine physicians, and researchers with a dependable source of information on current treatment options, tumor recurrence, and patient care. Evidence for current treatment options for de novo and recurrent glioblastoma, indications for local and topical therapies, immunotherapy, gene therapy, nanotherapy, small-molecule inhibition, electric tumor treating field stimulation, and antiangiogenic therapies and the role of Avastin. Recent advances relating to tumor resection, such as stereotactic laser ablation, diffusion tensor imaging, and fluorescent markers. Prognostic molecular and genetic markers and the impact of gene mutations on survival, as well as controversies relating to pseudo-progression. Lessons learned from unsuccessful interventions, as well as the most promising aspects of future glioblastoma research and treatment.

Produk Detail:

  • Author : Steven Brem
  • Publisher : Elsevier Health Sciences
  • Pages : 256 pages
  • ISBN : 032347974X
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKGlioblastoma E Book

Glioblastoma E-Book

Glioblastoma E-Book
  • Author : Steven Brem,Kalil G. Abdullah
  • Publisher : Elsevier Health Sciences
  • Release : 22 September 2016
GET THIS BOOKGlioblastoma E-Book

Clinically focused and designed to provide a to-the-point overview, Glioblastoma , by Drs. Steven Brem and Kalil G. Abdullah, brings you up to date with increased understanding, new treatment protocols, and recent advances in the field. Written by contributing specialists who are global experts in their respective areas, this one-stop reference provides neurosurgeons, medical-and-radiation oncologists, neuro-oncologists, neuropathologists, internal medicine physicians, and researchers with a dependable source of information on current treatment options, tumor recurrence, and patient care. Evidence for current treatment

Glioblastoma:

Glioblastoma:
  • Author : Swapan K. Ray
  • Publisher : Springer Science & Business Media
  • Release : 31 October 2009
GET THIS BOOKGlioblastoma:

Glioblastoma is the most malignant brain tumor that still remains incurable. It is such a deadly disease that patients do not survive more than a few months after diagnosis. Our understanding of the histopathology and molecular mechanisms of formation of glioblastoma is rapidly advancing so as to provide us clues for devising rational therapeutic strategies for treatment of this malignancy. It is important that we continue to improve our knowledge about the pathogenesis of this devastating disease and explore new

Glioblastoma Multiforme

Glioblastoma Multiforme
  • Author : Steven A. Rosenberg,Vincent T. DeVita, Jr.
  • Publisher : Jones & Bartlett Learning
  • Release : 28 October 2021
GET THIS BOOKGlioblastoma Multiforme

Treatment of malignant glioma remains a major challenge for neurosurgeons, neurologists, medical oncologists, and radiation oncologists caring for patients with these tumors. Glioblastoma multiforme, the most common type of brain tumor, is also the most deadly -- only five percent of patients or fewer will be alive at five years after diagnosis. This comprehensive new reference is edited by a renowned team consisting of a neurosurgeon, medical oncologist, oncologic surgeon, and radiation oncologist. The book provides basic researchers and clinicians

Precision Molecular Pathology of Glioblastoma

Precision Molecular Pathology of Glioblastoma
  • Author : José Javier Otero,Aline Paixao Becker
  • Publisher : Springer
  • Release : 19 May 2021
GET THIS BOOKPrecision Molecular Pathology of Glioblastoma

This volume provides a balanced and realistic review of the current state of glioblastoma, ranging from traditional histological review, molecular pathology of glioma, modern radiomics, neurosurgical focus, and integration of treatment plans by neuro-oncologists. The book reviews basic principles such as epidemiology and etiology, and modern 2016 WHO classification of CNS tumors. Chapters cover a general overview of common molecular techniques used in molecular pathology, molecular pathology in a developing country, key drivers of patient outcomes and predictors of response to

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
  • Author : Ramasamy Paulmurugan,Tarik F. Massoud
  • Publisher : Academic Press
  • Release : 25 June 2021
GET THIS BOOKGlioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies brings current knowledge from an international team of experts on the science and clinical management of glioblastoma chemoresistance. The book discusses topics such as molecular mechanisms of chemoresistance, experimental models to study chemoresistance, chemoresistance to drugs other than Temozolomide, and specific strategies to reverse chemoresistance. Additionally, it encompasses information on how to mitigate chemoresistance by targeted enhancement of p53 function. This book is a valuable resource for cancer researchers, oncologists,

Tumors of the Central Nervous System, Volume 1

Tumors of the Central Nervous System, Volume 1
  • Author : M. A. Hayat
  • Publisher : Springer
  • Release : 23 April 2013
GET THIS BOOKTumors of the Central Nervous System, Volume 1

The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant

A Statistic of One

A Statistic of One
  • Author : Stephen Hatrak
  • Publisher : iUniverse
  • Release : 01 May 2012
GET THIS BOOKA Statistic of One

"A Statistic of One: My Walk with Glioblastoma Multiforme" traces Stephen Hatrak's life from his diagnosis of glioblastoma multiforme, the deadliest of malignant brain tumors, to the present. He chronicles the trials and tribulations he faced and the losses he suffered along his journey. Faith and inner strength are formidable allies in overcoming any tragedy in one's life, and they played vital roles in his struggle. He was told from the start that the he might have twelve months to

Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America

Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America
  • Author : Linda M. Liau
  • Publisher : Elsevier Health Sciences
  • Release : 08 April 2021
GET THIS BOOKGlioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America

This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include—but are not limited to—Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel

Advances in Biology and Treatment of Glioblastoma

Advances in Biology and Treatment of Glioblastoma
  • Author : Kumaravel Somasundaram
  • Publisher : Springer
  • Release : 29 June 2017
GET THIS BOOKAdvances in Biology and Treatment of Glioblastoma

This volume covers the most important areas of glioblastoma – surgical resection, molecular pathology, targeted therapies, cancer stem cells, the role of DNA methylation, targeted sequencing for personalized therapy, animal models and advances in pediatric glioblastoma. Chapter authors are junior and senior investigators, who are well established in their particular areas and include neurosurgeons, neuropathologists, neurooncologists and basic scientists.

Fast Facts: Glioblastoma

Fast Facts: Glioblastoma
  • Author : Mairéad McNamara ,Sebastian Brandner,Stefanie C. Thust
  • Publisher : Karger Medical and Scientific Publishers
  • Release : 26 February 2020
GET THIS BOOKFast Facts: Glioblastoma

Glioblastoma (also known as glioblastoma multiforme) is a malignant intrinsic tumor thought to arise from populations of stem/progenitor cells in the brain. It is the most common aggressive intrinsic brain tumor in adults, with the potential to spread rapidly within the brain. Patients with glioblastoma face a poor prognosis, with median overall survival of approximately 15 months. However, our growing understanding of the molecular biology of gliomas means that this outlook may be improving. The identification of clinically relevant subgroups

Fast Facts: Glioblastoma

Fast Facts: Glioblastoma
  • Author : M. McNamara,S. Brandner,S.C. Thust
  • Publisher : Karger Medical and Scientific Publishers
  • Release : 26 February 2020
GET THIS BOOKFast Facts: Glioblastoma

Glioblastoma (also known as glioblastoma multiforme) is a malignant intrinsic tumor thought to arise from populations of stem/progenitor cells in the brain. It is the most common aggressive intrinsic brain tumor in adults, with the potential to spread rapidly within the brain. Patients with glioblastoma face a poor prognosis, with median overall survival of approximately 15 months. However, our growing understanding of the molecular biology of gliomas means that this outlook may be improving. The identification of clinically relevant subgroups

Tumors of the Central Nervous System, Volume 2

Tumors of the Central Nervous System, Volume 2
  • Author : M.A. Hayat
  • Publisher : Springer Science & Business Media
  • Release : 03 April 2011
GET THIS BOOKTumors of the Central Nervous System, Volume 2

Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are

Glioblastoma Multiforme

Glioblastoma Multiforme
  • Author : Isabelle Germano
  • Publisher : Unknown Publisher
  • Release : 01 September 2015
GET THIS BOOKGlioblastoma Multiforme

This book provides basic researchers and clinicians with a contemporary review of personalised medicine for the diagnosis and treatment of Glioblastoma Multiforme (GBM), the most common and most aggressive type of brain tumor. Over the past decade, there has been an explosion of basic and clinical research revolving around GBM, resulting in improved outcomes and, most importantly, significant advances in our ability to better understand this disease to formulate personalised medical treatment for each patient. It is important to note

Radiobiology of Glioblastoma

Radiobiology of Glioblastoma
  • Author : Luigi Pirtoli,Giovanni Luca Gravina,Antonio Giordano
  • Publisher : Springer
  • Release : 06 June 2016
GET THIS BOOKRadiobiology of Glioblastoma

This text properly considers the most recent and relevant advances in molecular RB of GB, taking into account the related topics of pathobiology, and underscores the most promising translational perspectives from the preclinical to the clinical domain. Section I (From Bedside to Bench) discusses conditions associated with RT resistance of GB and the consequent RB hints, technology improvements intended to overcome RT-resistance of GB, mathematical modeling of RB parameters from clinical studies, the present impact of molecular prognostic factors in

Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America, E-Book

Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America, E-Book
  • Author : Michael A Vogelbaum
  • Publisher : Elsevier Health Sciences
  • Release : 12 February 2021
GET THIS BOOKGlioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America, E-Book

This issue of Neurosurgery Clinics, guest edited by Dr. Michael A. Vogelbaum, is devoted to Glioblastoma, Part I: Surgical Management and Adjuncts. This is one of four issues selected each year by the series Consulting Editors, Russell R. Lonser and Daniel K. Resnick. Articles in this issue include: Perioperative Management of Patients with Glioblastoma, Role of Resection in Glioblastoma Management, Advancing Imaging to Enhance Surgery, Intraoperative Imaging for High-Grade Glioma Surgery, Use of Intraoperative Fluorophores, Extent of Resection of Glioblastoma,